Comparison of the medication method of paravertebral block in thoracoscopic lung lobectomy

Comparison of the medication method of paravertebral block in thoracoscopic lung lobectomy - Comparison of the medication method of paravertebral block in thoracoscopic lung lobectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026842

Enrollment

Registered

2017-04-05

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

0.25% levobupivacaine or 0.2% ropivacaine will be given after the surgery through the catheter of paravertebral block. 16 ml of a local anesthetic will be given every 8 hours until 48 hour after the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of ASA physical status 1 or 2 scheduled for thoracoscopic lung lobectomy

Exclusion criteria

Exclusion criteria: 1.Patients of ASA physical status 3 or 4. 2.Patients undergoing artifical dialysis. 3.Patients with hepatic failure. 4.Patients with infection 5.Patients with heart failur (NYHA 3 or 4) 6.patients with a pacemaker because of arrhythmia.

Design outcomes

Primary

Measure	Time frame
Total amount of fentanyl which was injected by IV-PCA after the surgery	—

Secondary

Measure	Time frame
The change of plasma concentration of regional anesthetic agents in both groups.	—

Countries

Japan

Contacts

Public ContactTakahashi Keiya

Asahikawa Medical University Department of Anesthesiology and Critical Care Medicine

k2341@asahikawa-med.ac.jp0166652111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026